Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, Assaf Weiner, Noy Cohen Saban, Tali Feferman, Ido Amit, Rony Dahan
Topics & Concepts
AntibodyTherapeutic windowWindow (computing)ChemistryPharmacologyMedicineImmunologyComputer scienceOperating systemImmunotherapy and Immune ResponsesMonoclonal and Polyclonal Antibodies ResearchT-cell and B-cell Immunology